Skip to main content

letter

. 1983 Jan 1;286(6358):57. doi: 10.1136/bmj.286.6358.57

High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.

K J Sheppard, D A Bradbury, J M Davies, D R Ryrie

PMCID: PMC1546636 PMID: 6295542

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Carmel R., Eisenberg L. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer. 1977 Sep;40(3):1348–1353. doi: 10.1002/1097-0142(197709)40:3<1348::aid-cncr2820400352>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
Jacobs W. L., Zondag H. A. Radioisotope assay of vitamin B12 in human blood serum. Clin Chim Acta. 1969 Apr;24(1):93–103. doi: 10.1016/0009-8981(69)90145-4. [DOI] [PubMed] [Google Scholar]
Mortensen E. Negative interference by residual proteins in the supernatant fluid used in radioisotopic assay of serum vitamin B 12 . Clin Chem. 1972 Sep;18(9):895–900. [PubMed] [Google Scholar]

ACTIONS

RESOURCES